These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 32063053)
1. Efficient 1-Hour Technetium-99 m Pyrophosphate Imaging Protocol for the Diagnosis of Transthyretin Cardiac Amyloidosis. Masri A; Bukhari S; Ahmad S; Nieves R; Eisele YS; Follansbee W; Brownell A; Wong TC; Schelbert E; Soman P Circ Cardiovasc Imaging; 2020 Feb; 13(2):e010249. PubMed ID: 32063053 [TBL] [Abstract][Full Text] [Related]
2. Comparison of 1-h with 3-h planar Saitou T; Aikawa T; Manabe O; Nagase A; Kudo T; Oyama-Manabe N Ann Nucl Med; 2023 Feb; 37(2):99-107. PubMed ID: 36352186 [TBL] [Abstract][Full Text] [Related]
3. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849 [TBL] [Abstract][Full Text] [Related]
4. Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: Imaging at 1 vs 3 hours and planar vs SPECT/CT. Sperry BW; Burgett E; Bybee KA; McGhie AI; O'Keefe JH; Saeed IM; Thompson RC; Bateman TM J Nucl Cardiol; 2020 Oct; 27(5):1802-1807. PubMed ID: 32415627 [TBL] [Abstract][Full Text] [Related]
5. Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls. Asif T; Gomez J; Singh V; Doukky R; Nedeltcheva A; Malhotra S J Nucl Cardiol; 2021 Feb; 28(1):104-111. PubMed ID: 32901418 [TBL] [Abstract][Full Text] [Related]
6. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580 [No Abstract] [Full Text] [Related]
7. Tc-99m-pyrophosphate scintigraphy for the diagnosis of ATTR cardiac amyloidosis: Comparison of quantitative and semi-quantitative approaches. Régis C; Harel F; Martineau P; Grégoire J; Abikhzer G; Juneau D; Pelletier-Galarneau M J Nucl Cardiol; 2020 Oct; 27(5):1808-1815. PubMed ID: 32476105 [TBL] [Abstract][Full Text] [Related]
8. Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality. Sperry BW; Vranian MN; Tower-Rader A; Hachamovitch R; Hanna M; Brunken R; Phelan D; Cerqueira MD; Jaber WA JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):234-242. PubMed ID: 28917675 [TBL] [Abstract][Full Text] [Related]